Studies demonstrate that BM microenvironment, including BM stromal cells (BMSC) [8], paracrine signaling loops involving cytokines interleukin-6 (IL-6) and insulin-like growth factor-I (IGF-I) [9], plays pivotal roles in myeloma pathogenesis and drug resistance. The gene discussed is IGF1; the disease is plasma cell myeloma.